Journal of Radiology
Open Access

Transabdominal inside sonography (TABS) with high-recurrence ultrasound (US) is a quick, effective, modest, very much acknowledged approach to inspecting the digestive tract, with no radiation perils. With or without loss of stratification or haustra, it is able to detect an increase in bowel wall thickness (BWT), which is considered a specific symptom of inflammatory bowel disease (IBD). Additionally, the color Doppler method can help assess the activity of IBD by detecting blood flow within the bowel wall as a possible sign of inflammation. The purpose of our research was to determine how useful color Doppler and high-resolution abdominal ultrasound are for diagnosing IBD and its complications [1].

This study included forty patients who presented with colonic symptoms to Cairo University’s Gastrointestinal and Liver Endoscopy Unit; Twenty of the control groups had symptoms of colonic nondiarrhea but no endoscopically detected lesions, while the remaining twenty had IBD that was diagnosed by endoscopy and histopathology.

Our findings were: 75% accuracy for color Doppler, which is crucial in detecting hypervascularity as a sign of inflammation, and 85% accuracy for high-resolution ultrasound in diagnosing IBD based on increased BWT (but it could not differentiate between different types of inflammatory bowel conditions that also presented by increase in the BWT). We came to the conclusion that pulsed Doppler can be used to monitor the changes in the pulsed Doppler as those patients go through multiple periods of remission and relapse, and that US is helpful for localizing, following up, and monitoring treatment for IBD [2].

Magnetic resonance imaging in Bowels Disease

MRI (Magnetic Resonance Imaging) can be a useful diagnostic tool in evaluating bowel diseases. Some key factors that can be evaluated using MRI for bowel diseases include:

Inflammation: MRI can detect inflammation in the bowel wall, which is a hallmark of many bowel diseases, such as Crohn’s disease, ulcerative colitis, and diverticulitis. Inflammatory changes in the bowel wall can be seen as thickening, increased contrast enhancement, and edema.

Fistulas and Abscesses: MRI can detect the presence of fistulas (abnormal connections between organs) and abscesses (collections of pus) in the bowel wall. These are common in Crohn’s disease and can be seen as fluid collections on MRI.

Strictures: Bowel strictures (narrowing of the bowel) can be evaluated using MRI. MRI can provide information about the location and severity of strictures, which can be helpful in planning treatment.

Perforation: MRI can detect bowel perforation, which is a serious complication of bowel diseases. Bowel perforation can be seen as free fluid in the abdominal cavity.

Tumor: MRI can detect tumors in the bowel, which can be benign or malignant. Tumors can be seen as masses on MRI with or without bowel wall thickening.

Obstruction: MRI can also evaluate for bowel obstruction, which is a common complication of bowel diseases. Bowel obstruction can be seen as distention of the bowel loops with fluid and gas.

Overall, MRI can provide valuable information for the diagnosis and management of bowel diseases [3-5].

Conclusion

Bowel diseases are a group of conditions that affect the digestive system, including the intestines, colon, and rectum. There are many types of bowel diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, diverticulitis and colon cancer.

Symptoms of bowel diseases can vary depending on the specific condition, but they may include abdominal pain, diarrhea, constipation, blood in the stool and weight loss. Diagnosis typically involves a combination of medical history, physical examination, blood tests, imaging studies and colonoscopy. Treatment for bowel diseases may involve medication, dietary changes, lifestyle modifications and surgery in some cases. Overall, bowel diseases can be complex and challenging to manage but with proper diagnosis and treatment many people are able to manage their symptoms and live healthy and active lives.

Acknowledgement

None

Conflict of Interest

None

1. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317.

Indexed at, Google Scholar, Crossref

2. Danese S, Fiocchi C (2011) Ulcerative colitis. N Engl J Med 365: 1713-1725.

Indexed at, Crossref

3. Loftus EV Jr. (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.

Indexed at, Google Scholar, Crossref

4. Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152: 313-321.

Indexed at, Google Scholar, Crossref

5. Matsuoka K, Kanai T (2015) The gut microbiota and inflammatory bowel disease. Semin Immunopathol 37: 47-55.

Indexed at, Google Scholar, Crossref